You are here: Industry Insights > J&J

News List

FDA halts COVID-19 vaccine production at Emergent facility europeanpharmaceuticalreview
April 22, 2021
The FDA has requested Emergent’s Bayview plant be closed and vaccine production halted while the agency investigates potential good manufacturing practice (GMP) violations.
J&J to restart Covid-19 vaccine shipment in Europe pharmaceutical-technology
April 22, 2021
Johnson & Johnson (J&J) is set to resume shipment of the single-shot Covid-19 vaccine in Europe following a positive review by the European Medicines Agency (EMA).
Greater risk of brain clots from COVID-19 compared with vaccines: UK researchers expresspharma
April 19, 2021
The study was based on a US health database, and so did not accrue new data on the risk of clots from AstraZeneca's vaccine directly, as the shot is not being rolled out there.
FDA, CDC calling to halt distribution of J&J vaccine is a blow to global vaccine effort: GlobalData expresspharma
April 16, 2021
Following the news that the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) released a joint statement calling for an immediate pause to the use of the Johnson & Johnson (J&J) vaccine.
European Commission to not renew AstraZeneca and J&J vaccine contracts at expiry: Reports expresspharma
April 15, 2021
The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays in COVID-19 vaccine deliveries to the EU.
US halts J&J COVID-19 vaccine after six women under 50 develop rare blood clots expresspharma
April 14, 2021
US federal health agencies recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women under 50 given the shot developed rare blood clots, dealing a fresh setback to efforts to tackle the pandemic.
EMA initiates review of J&J’s Covid-19 vaccine over blood clot reports pharmaceutical-technology
April 13, 2021
The European Medicines Agency (EMA) has initiated review of Johnson & Johnson’s (J&J) single-shot Covid-19 vaccine over reports of rare blood clots in four individuals in the US.
J&J in discussions with Indian regulator to begin trial of single-dose vaccine expresspharma
April 12, 2021
India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme.
J&J expands Phase 2a COVID-19 vaccine trial to include adolescents expresspharma
April 06, 2021
Johnson & Johnson has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.
US gives charge of facility that botched COVID vaccine to J&J, stops AstraZeneca from using the plant expresspharma
April 06, 2021
AstraZeneca, whose vaccine has not been approved in the US, said it will work with President Joe Biden’s administration to find an alternative site to produce its vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page